Kuala Lumpur, Malaysia, Nov. 20, 2026 Globe Newswire -- Alps Group Inc Alps or the Company Nasdaq ALPS , an integrated biotechnology platform headquartered in Malaysia, today announced that it has received written notifi
Why Is Alps Group Inc (ALPS) Stock Down Today?
Updated Nov 22, 2026 6:09 AM ET ยท Prev Close $1.19
Session Regime & Catalyst Assessment
68% Signal ConvictionAlps Group Inc Pulling Back 3.36% on 1.00x Relative Volume
Alps Group Inc (ALPS) is pulling back 3.36% (-$0.04) to $1.15 on 1.00x average session volume. Relative to benchmarks, ALPS is trading in line with the S&P 500 (+0.28% alpha). 14-day RSI stands at 66.8, keeping momentum in a bullish regime.
Kuala Lumpur, Malaysia, Nov. 20, 2026 Globe Newswire -- Alps Group Inc Alps or the Company Nasdaq ALPS , an integrated biotechnology platform headquartered in Malaysia, today announced that it has received written notifi
Price ($1.15) holds above both 20-day ($0.79) and 50-day ($0.54) moving averages.
Market & Sector Relative Strength
ALPS trading in line with the S&P 500 (+0.28% alpha)Recent ALPS Catalyst Headlines
Verified WirePCI Positions MyGenome as Southeast Asia's Reference Laboratory for Drug Interaction Safety ScienceKUALA Lumpur, Malaysia, Nov. 12, 2026 Globe Newswire -- Alps Group Inc Alps or the Company Nasdaq ALPS , an integrated bi
Kuala Lumpur, Malaysia, Oct. 30, 2026 Globe Newswire -- Alps Group Inc Alps or the Company Nasdaq ALPS , an integrated biotechnology platform headquartered in Malaysia, today announced that its shareholders approved, in
Revenue Grew 44 to 4.9 Million, Led by Continued Growth Across Cellular Therapy, Medical Testing, Laboratory and Aesthetics Beauty Services, and Healthcare Products Began Trading on the Nasdaq Global Market Under the Tic
1โ3 Day Expected Range & Key Level
54% Follow-ThroughMonitor volume expansion above 1.5x RVOL around $1.10 (session support) for directional breakout confirmation.
Technical Regime (ALPS)
BULLISH MA TRENDRetail & Crowd Sentiment
QuietA bullish trader on StockTwits announced a purchase of $ALPS stock.
About Alps Group Inc
Get Instant ALPS Catalyst Alerts
Receive an email alert when ALPS triggers an unusual volume breakout, options sweep, or rating shift.
ALPS Session & Catalyst FAQ
Why is ALPS stock down today?
Alps Group Inc (ALPS) is pulling back 3.36% (-$0.04) to $1.15 on 1.00x average session volume. Relative to benchmarks, ALPS is trading in line with the S&P 500 (+0.28% alpha). 14-day RSI stands at 66.8, keeping momentum in a bullish regime.
Is ALPS stock a buy or sell right now?
Today's session carries a 68% catalyst conviction score on 1.00x relative volume (moderate participation). Our multi-factor model currently rates ALPS as EXTENDED. Review full valuation, quality, and timing signals on the ALPS Buy or Sell Decision Brief โ
What is ALPS's intrinsic value and expected trading range?
At $1.15, ALPS's modeled 1-to-3 session range is $1.09 โ $1.21, with a key inflection level at $1.10 (session support). Compare current price against multi-year cash flow projections in the ALPS Intrinsic Value & DCF Model โ and Market Cycle Phase Tracker โ
What do RSI and moving averages signal for ALPS?
RSI at 66.8 reflects constructive bullish momentum. ALPS trades at $1.15 relative to its 20-day SMA ($0.79) and 50-day SMA ($0.54), reflecting a bullish moving-average structure.
Tradestie Flagship Research & Market Hubs
Live institutional catalyst tape ranking liquid gainers, losers, options sweeps, and RVOL surges.
Track spot H100/B200 compute rental rates and frontier LLM inference token economics.
Wafer yield, CoWoS packaging, and HBM bill-of-materials teardown models across AI accelerators.
Monitor engineering velocity and upstream foundry wafer demand inflections across tech leaders.
Live conviction tracking, invalidation guardrails, and thesis health checks on flagship ideas.
Backtest-validated unusual options positioning and open-interest accumulation setups.
Daily ranked quantitative leaderboard with audited forward-return track record vs S&P 500.
High-yield, quality-screened cash-secured put and put-spread income candidates.